3557 results for «395»

Filter By

3557 results

Mitral valve disease: diagnosis and treatment selection

23 Nov 2021 – From PCR London Valves 2021

In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.

Mitral valve disease: diagnosis and treatment selection

Pushing boundaries in tricuspid therapy - The TricValve solution

22 Dec 2021 – From GulfPCR-GIM 2021

In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.

Pushing boundaries in

Optimising TAVI results in patients with small aortic annuli

22 Dec 2021 – From GulfPCR-GIM 2021

This session will enable you to discuss the clinical outcomes of TAVI results in patients with small aortic annuli, learn how to best measure and assess gradients when performing TAVI, and review a case of a patient with small annuli treated with TAVI.

Optimising TAVI results

Tricuspid valve disease: state-of-the-art

23 Nov 2021 – From PCR London Valves 2021

Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...

Tricuspid valve disease: state-of-the-art

Anatomy of the aortic valvar complex with considerations for optimal TAVI positioning

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 simulation-based learning session, learn the latest in transcatheter aortic valve implantation, gain an understanding of anatomical features, review imaging modalities to plan and perform procedures, and witness hands-on activities, among others.

Anatomy of the aortic valvar complex with considerations for optimal TAVI positioning

Complete revascularisation: from defining PCI strategy to PCI optimisation

22 Dec 2021 – From GulfPCR-GIM 2021

In this session on percutaneous coronary intervention, learn about available physiology tools for a full coronary assessment, understand how OCT impacts decision-making to strategise and optimise PCI, and learn through case examples how the use of physiology and OCT impacts daily practice.

Complete revascularisation:

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.

Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

18 May 2021 – From EuroPCR 2021

Watch this session presented by Raul Moreno and Dave Smith in order to learn about the hemodynamic performance of the ALLEGRA TAVI system, to share the experience of European centres through challenging ALLEGRA cases, and to focus on the outcome of the ALLEGRA TAVI system in small annuli...

The uncompromised hemodynamics of the ALLEGRA transfemoral TAVI system in native and small annuli

Complex PCI with short DAPT: the trade-off between ischaemia and bleeding

18 May 2021 – From EuroPCR 2021

Watch this session presented by Benjamin Faurie, Roxana Mehran and Manel Sabate in order to understand the trade-off between ischaemic risk and bleeding risk, to hear about the results of LM-PCI with Biofreedom Ultra and short DAPT, and to learn how to use short DAPT in patients undergoing complex...

Complex PCI with short DAPT: the trade-off between ischaemia and bleeding

Short DAPT in high bleeding risk: ready for prime time?

20 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Davide Capodanno, Pieter Smits and Marco Valgimigli in order to discuss integrated framework for the decision making on DAPT duration in high bleeding risk patients, to understand the implications of the available evidence and gaps in knowledge, and to learn...

Short DAPT in high bleeding risk: ready for prime time?

30 years of Rotary ablation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Maurice Buchbinder to learn all about the history of rotary ablation, from its invention 30 years ago to its current practice, and discover various cases highlighting the results of this therapy. 

30 years of Rotary ablation

EBC MAIN overview and the impact on clinical practice

18 May 2021 – From EuroPCR 2021

Watch this session presented by David Hildick-Smith, Jens Flensted Lassen and Goran Stankovic in order to learn more about this important study and understand the impact to clinical practice, to gain insights from an interesting EBC main case, and to listen to the expert's perspectives on other recent...

EBC main overview and the impact to clinical practice

Early real-world experience with Tendyne™ TMVR

18 May 2021 – From EuroPCR 2021

Watch this session presented by Stephan von Bardeleben in order to learn about real-world Tendyne results from TENDER EU, the largest reported commercial cohort, to hear expert feedback on the safety and effectiveness of Tendyne TMVI in real-life setting, and to discover how one heart team integrates Tendyne...

Early real-world experience with Tendyne™ TMVR

Abluminus DES+: an innovative solution going global to beat diabetes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roxana Mehran, Luca Testa, Alexandre Abizaid and Marie-Claude Morice in order to know more about the need of a dedicated DES+ for diabetic patients and the technology behind it and the updates on ongoing and upcoming studies and trials, as well...

Abluminus DES+: an innovative solution going global to beat diabetes

Paclitaxel and sirolimus coated balloons: create evidence before claims

20 May 2021 – From EuroPCR 2021

Watch this session presented by Mohd Ali Rosli, Bruno Scheller, Raban Jeger and Sylvia Otto in order to join a controversial discussion about a sirolimus and paclitaxel coated balloon approach, to follow a dedicated discussion on existing evidence on efficacy and safety for paclitaxel and sirolimus coated balloons...

Paclitaxel and sirolimus coated balloons: create evidence before claims

Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme

20 May 2021 – From EuroPCR 2021

Watch this session presented by Simon Kennon, Olivier Darremont, Helene Eltchaninoff, Derk Frank, Sandra Lauck and Francesco Saia in order to improve access to high quality of care with safe early discharge for selected patients in Europe, to identify strategies to reduce hospital stay and optimise TAVI programmes for...

Optimise your TAVI patient's outcomes: implementing the Edwards benchmark programme

EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in BRS/BVS:

  • Magnesium-based Bioresorbable Scaffold in STEMI: 2 years results
  • France Absorb registry: final five years follow-up
  • A randomized trial of thinner-strut sirolimus-eluting BRS in de novo lesions
  • Three-year follow-up of the prospective bvs stemi strategy-it study
  • Final five-year results of AIDA trial
  • Bioresorbable...
EuroPCR 2021 Hotlines / Late-Breaking Trials: MAGSTEMI, France ABSORB, FUTURE-II, STRATEGY-IT, AIDA, and PRAGUE 22

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

20 May 2021 – From EuroPCR 2021

Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...

Empowering DES performance in complex patients to maximise efficacy and safety outcomes

EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

21 May 2021 – From EuroPCR 2021

Find out more about various studies & registries in drugs & devices:

  • POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
  • CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
  • PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM

The new Evolut PRO+ system: optimal procedural outcomes in all patients

20 May 2021 – From EuroPCR 2021

Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...

The new Evolut PRO+ system: optimal procedural outcomes in all patients
Didn’t find what you were looking for?